基于人工智能的骨髓增生异常综合征评分、2022 分类和国际分子预后评分系统：完美匹配。

IF 8.2 1区医学 Q1 HEMATOLOGY

Haematologica Pub Date : 2024-10-10 DOI:10.3324/haematol.2024.286340

Valentin Clichet, Thomas Boyer

引用次数: 0

摘要

不详。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Artificial intelligence-based Myelodysplastic Syndromes Score, 2022 classifications, and the Molecular International Prognostic Scoring System : a perfect match.

Not available.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Haematologica 医学-血液学

CiteScore

14.10

自引率

2.00%

发文量

349

审稿时长

3-6 weeks

期刊介绍： Haematologica is a journal that publishes articles within the broad field of hematology. It reports on novel findings in basic, clinical, and translational research. Scope: The scope of the journal includes reporting novel research results that: Have a significant impact on understanding normal hematology or the development of hematological diseases. Are likely to bring important changes to the diagnosis or treatment of hematological diseases.